IVC reconstruction during oncologic resections is safe, with robust mid-term outcomes.
- 80 patients treated; 94%+ primary patency at 2 years.
- 30-day survival rate was 96.3%, with 2- and 3-year survival at 76.8%.
Most thrombosis occurrences tied to tumor recurrence or technical issues.
Consider this technique in high-volume centers for complex oncologic cases.
Journal Article by Furtado Neves PJ, Simioni A (…) Malgor RD et 5 al. in J Am Coll Surg
Copyright © 2026 by the American College of Surgeons. Published by Wolters Kluwer Health, Inc. All rights reserved.
